OpenAI plans to back a competitor to Elon Musk’s Neuralink in the brain-computer interface market, the Financial Times reported.
Merge Labs aims to raise $250 million for a valuation of $850 million, with much of the funding coming from the maker of ChatGPT, sources told the news outlet. OpenAI co-founder Sam Altman would reportedly co-found the new company but not run it day to day. OpenAI declined to comment to the publication.
Neuralink most recently raised $650 million at a $9 billion valuation, and has received funding from Mr. Altman, according to the Aug. 12 story. Mr. Musk’s company has been implanting brain chips in patients at U.S. hospitals, including a paralyzed man at University of Miami Health System who can now control his smartphone and computer with his thoughts.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
